- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT05038319
SAFETY AND EFFICACY OF ENDOSCOPIC CONVENTIONAL CYANOACRYLATE GLUE VS EUS-GUIDED COIL PLUS CYANOACRYLATE TECHNIQUE IN THE TREATMENT OF GASTRIC VARICES: A RANDOMIZED CONTROLLED TRIAL (GLUE)
SAFETY AND EFFICACY OF ENDOSCOPIC CONVENTIONAL CYANOACRYLATE GLUE VS EUS-GUIDED COIL PLUS CYANOACRYLATE TECHNIQUE IN THE TREATMENT OF GASTRIC VARICES
To compare safety and efficacy of Endoscopic conventional technique (cyanoacrylate alone) to the EUS-guided injection technique (coil and cyanoacrylate) in the treatment of gastric varices.
Methods:
Patient recruitment:
Patients would be recruited from the endoscopy centre prior to their scheduled endoscopic intervention.
Study intervention :- Cyanoacrylate injection and EUS guided coil and glue injection The procedures would be performed by experienced endoscopists. The procedure would be performed under conscious sedation or monitored anaesthesia. The procedures would be performed by a therapeutic endoscope with the through the scope method. The endoscope would be used to reach the site of Varices. In Conventional technique treatment with cyanoacrylate the injection was performed using a 23-G sclerotherapy needle catheter (Interject®,Cook). One vial of N-butyl-2-cyanoacrylate (0.5 mL) was mixed with Lipiodol® in a 1:1 ratio, and injected intravesically as a 1 mL bolus. The injection was repeated until total hardening of the varix. In treatment with coil and cyanoacrylate once the gastric varix was identified, the total diameter of the vascular pseudotumor was measured and the puncture was made at the site of the widest varix. The puncture was performed using a 19 G needle (Expect®,Cook). The size of the coil used was selected based on the size of the widest varix in the pseudotumor; the size of the coil after release should not be greater than the caliber of the vessel. Following coil deployment, 2 mL of distilled water was injected, followed by one vial (0.5 mL) of N-butyl-2-cyanoacrylate mixed with Lipiodol in 1:1 ratio. Then, another 2 mL of distilled water was injected, and the needle was removed.
COIL and GLUE:
Cyanoacrylate injection remains the conventional treatment method. Since coils were first used to treat ectopic varices by Levy in 2008(6), this technique has been increasingly implemented into clinical practice. However, its higher cost has been a limiting factor in more widespread use.
Depending on the ectasia of the varix the following coil was deployed: 8 mm x 20 cm, 10 mm x 20 cm, or 10 mm x 30 cm (Interlock-18 Fibered IDC Occlusion System,Cook).
D.2.5 Randomization Patients were randomized into two groups: group I received standard endoscopic treatment with injection of a cyanoacrylate/Lipiodol (1:1) solution and group II received EUS-guided coiling and cyanoacrylate injection treatment A computer-based randomization list was generated with the online software Research Randomizer with 1:1 ratio (www.randomizer.org). An independent researcher not involved in this trial created the randomization list and sealed sequential opaque envelopes containing the random allocation sequence. The complete list generation occurred before the first enrollment.
D.2.6 Post-procedural management After the procedure, EUS with Doppler flow evaluation was repeated to check the presence or absence of flow within the varix. The patients remained under observation in the GI endoscopy unit for at least one hour, being released if no complaint was reported. After endoscopic treatment, all patients underwent thoracic and abdomen computerized tomography (CT) scanning within one week, independent of the development of clinical symptoms.
Panoramica dello studio
Descrizione dettagliata
All patients returned to the GI endoscopy unit approximately one month after initial endoscopic intervention for a repeat EUS evaluation.
Technical success is defined as complete obliteration of varices and absence of flow signal.On this occasion, if any residual flow was identified, new treatment was performed following the same technique initially used, and another evaluation was thus performed one month later. This scenario was repeated until complete thrombosis was achieved.
Complications that occurred during the procedure or within seven days post-intervention were defined as early complications, whereas those that occurred greater than or equal to seven days post-intervention were defined as late complications.
Recurrence was defined as evidence of any flow within the varix which occurred after initial obliteration had been confirmed.
5.Esophageal stricture 6.Iodine allergy (for EV)
Follow-up:
Once complete thrombosis was achieved, follow-up evaluations were performed three and nine months later (i.e. four and 10 months after therapy), at which time patients were questioned about any post-procedure complications, and underwent another EUS examination, which permitted repeat evaluations of flow within the treated vessel.
Tipo di studio
Iscrizione (Anticipato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Satya Maharshi Tummalapalli, MBBS MD
- Numero di telefono: 04023378888
- Email: maharshi2059@gmail.com
Backup dei contatti dello studio
- Nome: RAJESH GOUD, M.PHARMA, MBA
- Numero di telefono: 04023378888
- Email: rajeshgoud761@gmail.com
Luoghi di studio
-
-
Telangana
-
Hyderabad, Telangana, India, 500082
- Reclutamento
- Asian Institute of Gastroenterology
-
Contatto:
- SATYA MAHARSHI, MBBS MD
- Numero di telefono: 04023378888
- Email: maharshi2059@gmail.com
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Age ≥18 years old, patients diagnosed with
- gastric varices larger than 2.0 cm in total diameter of the vascular pseudotumor type GOV2 or IGV 1.
- Active bleeder
- Secondary prophylaxis - h/o previous bleed
- High risk GV (GOV 2/IGV 1) - Baveno VI-
- Primary prophylaxis
Excusion criteria:
- Previous HRS
- MOF
- Platelet <50,000/cumm
- INR>2
- Esophageal stricture
- Iodine allergy (for EV)
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Cyanoacrylate injection and EUS guided coil and glue injection
The procedure would be performed under conscious sedation.The endoscope would be used to reach the site of Varices.
In Conventional technique treatment with cyanoacrylate the injection was performed using a 23-G sclerotherapy needle catheter .
One vial of N-butyl-2-cyanoacrylate (0.5 mL) was mixed with Lipiodol) in a 1:1 ratio, and injected intravesically as a 1 mL bolus.
The injection was repeated until total hardening of the varix.
In treatment with coil and cyanoacrylate once the gastric varix was identified, the total diameter of the vascular pseudotumor was measured and the puncture was made at the site of the widest varix.
The puncture was performed using a 19 G needle .
the size of the coil after release should not be greater than the caliber of the vessel.
Following coil deployment, 2 mL of distilled water was injected, followed by one vial (0.5 mL) of N-butyl-2-cyanoacrylate mixed with Lipiodol in 1:1 ratio.
|
The procedures would be performed by a therapeutic endoscope with the through the scope method.
The endoscope would be used to reach the site of Varices.
|
|
Comparatore placebo: COIL and GLUE
Cyanoacrylate injection, first published by Soehendra in 1986, remains the conventional treatment method. Since coils were first used to treat ectopic varices by Levy in 2008(6), this technique has been increasingly implemented into clinical practice. However, its higher cost has been a limiting factor in more widespread use. Depending on the ectasia of the varix the following coil was deployed: 8 mm x 20 cm, 10 mm x 20 cm, or 10 mm x 30 cm (Interlock-18 Fibered IDC Occlusion System,Cook). |
The procedures would be performed by a therapeutic endoscope with the through the scope method.
The endoscope would be used to reach the site of Varices.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Primary outcome was to compare the occurrence of embolism in the two groups
Lasso di tempo: 4 months
|
Technical success is defined as complete obliteration of varices and absence of flow signal.On this occasion, if any residual flow was identified, new treatment was performed following the same technique initially used, and another evaluation was thus performed one month later.
This scenario was repeated until complete thrombosis was achieved.
|
4 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Secondary outcome was to evaluate the efficacy of the two techniques in the eradication of the varices.
Lasso di tempo: 9 MONTHS
|
Technical success is defined as complete obliteration of varices and absence of flow signal.On this occasion, if any residual flow was identified, new treatment was performed following the same technique initially used, and another evaluation was thus performed one month later.
This scenario was repeated until complete thrombosis was achieved.
|
9 MONTHS
|
Collaboratori e investigatori
Investigatori
- Direttore dello studio: RAJESH GUPTA, MBBS MD, Asian Institute of Gastroenterology Pvt Ltd
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- EUS GLUE 001
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su EUS
-
Fondazione del Piemonte per l'OncologiaReclutamentoTumori gastrointestinali sottoepitelialiItalia
-
Istituto Clinico HumanitasReclutamentoOstruzione biliare malignaItalia
-
Weill Medical College of Cornell UniversitySconosciutoTumore del pancreas | Colangiocarcinoma | Cancro del dotto biliare | Pancreatite cronica | Stenosi biliare | Ostruzione biliare | Cancro ampollare | Ostruzione dello stent | Stenosi del dotto prossimale | Stenosi del dotto distale | Stenosi dello sfintere biliare | Pietre colpite | Diverticoli periampollari | Anatomia...Stati Uniti, Brasile
-
Technical University of MunichSconosciutoDolore addominaleGermania
-
Centre hospitalier de l'Université de Montréal...SospesoAdenocarcinoma duttale pancreaticoCanada
-
Asian Institute of Gastroenterology, IndiaNon ancora reclutamentoLiquido di cisti pancreatiche
-
University of Colorado, DenverUS EndoscopyReclutamentoCisti pancreaticaStati Uniti
-
University of FloridaJohns Hopkins University; Mayo Clinic; Yale University; Columbia University; Ochsner... e altri collaboratoriCompletatoGastroenterologia | LesioniStati Uniti
-
National Cancer Center, KoreaCompletatoCancro ai polmoniCorea, Repubblica di
-
University of BolognaCompletatoLesione; Gastrointestinale | Malattie del fegato, delle vie biliari, del pancreas e dell'apparato gastrointestinale, nnItalia